CANDESARTAN-AMLODIP Mepha caps 8mg/10mg 28 pce

7680676560058 CH-67656 C09DB07 02.07.1.

Reimbursement limitations:

CANDESART-AM

Le traitement combiné d’une association fixe de candésartan et amlodipine et d'un antagoniste du calcium …

CANDESARTAN-AMLODIP Mepha caps 8mg/10mg 28 pce
CANDESARTAN-AMLODIP Mepha caps 8mg/10mg 28 pce
CANDESARTAN-AMLODIP Mepha caps 8mg/10mg 28 pce
1 / 3
google

Details

Product number
6765603
CPT
-
Packaging group
28
Unit
Kapsel(n)
Composition
candesartanum cilexetilum 8 mg, amlodipinum 10 mg ut amlodipini besilas, lactosum monohydricum 211.9 mg, maydis amylum, carmellosum calcicum, macrogolum 8000, hydroxypropylcellulosum, magnesii stearas, Kapselhülle: E 104, E 172 (flavum), E 171, gelatina, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula.

Articles (1)

Candesartan-Amlodipin-Mepha 8 mg/10 mg, Hartkapseln
Kapseln
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/05/2025
Patient information leaflet
Français
09/05/2025
Patient information leaflet
Italien
09/05/2025
Professional SmPC
Allemand
09/05/2025
Professional SmPC
Français
09/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
8.0 MG Substance Wirkstoff (Principe actif)
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
211.9 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FTODK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 35.95
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2021

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
67656
Drug name
Candesartan-Amlodipin-Mepha, Hartkapseln
Galenic form
KAPS
ATC Code
C09DB07
Authorization status
Z
Dispensation category
B
First authorization
23/12/2020
Authorization expiration date
31/12/9999
IT number
02.07.1.
Domain
Human medicine
Field of application
Essentielle Hypertonie

Packaging details

Description (FR)
CANDESARTAN-AMLODIP Mepha caps 8mg/10mg 28 pce
Description (DE)
CANDESARTAN-AMLODIP Mepha Kaps 8mg/10mg 28 Stk
Market launch
23/12/2020
Narcotic (BTM)
No

Other packaging sizes

CANDESARTAN-AMLODIP Mepha caps 8mg/5mg 28 pce
28 KAP
View
CANDESARTAN-AMLODIP Mepha caps 8mg/5mg 98 pce
98 KAP
View
CANDESARTAN-AMLODIPI Mepha caps 16mg/5mg 28 pce
28 KAP
View
CANDESARTAN-AMLODIPI Mepha caps 16mg/5mg 98 pce
98 KAP
View
CANDESARTAN-AMLODIP Mepha caps 8mg/10mg 98 pce
98 KAP
View
CANDESARTAN-AMLODIP Mepha caps 16mg/10mg 28 pce
28 KAP
View
CANDESARTAN-AMLODIP Mepha caps 16mg/10mg 98 pce
98 KAP
View